Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 40Kidney Neoplasms 30Melanoma 25Prostatic Neoplasms 24Breast Neoplasms 18Wilms Tumor 16Neoplasm Metastasis 16Ovarian Neoplasms 14Carcinoma, Non-Small-Cell Lung 12Testicular Neoplasms 11Multiple Myeloma 11Uterine Cervical Neoplasms 10Sarcoma 9Pancreatic Neoplasms 9Neuroblastoma 9Testicular Germ Cell Tumor 8Lymphoma, Follicular 8Lymphoma 8Lung Neoplasms 8Hodgkin Disease 8Carcinoma, Hepatocellular 8Triple Negative Breast Neoplasms 7Neoplasms, Plasma Cell 7Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myeloid, Acute 7Leukemia, Lymphocytic, Chronic, B-Cell 7

Interventions

Docetaxel 4radium Ra 223 dichloride 2Prednisone 2sargramostim 1gossypol acetic acid 1epothilone B 1cabazitaxel 1bafetinib 1Sunitinib 1PE regimen 1Mycobacterium w vaccine 1Interleukin-2 1Injections 1Everolimus 1Etoposide 1Denosumab 1Cyclophosphamide 1Cisplatin 1Carboplatin 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hormone Refractory Prostate Cancer × Cyclophosphamide × Genitourinary × Clear all
NCT02867345 2019-03-06

PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer

Peking University

Withdrawn
Genitourinary

Hormone Refractory Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡